-
- immunoMUSE® enables flexible, high-sensitivity multiplex immunofluorescence with user-defined antibodies.
Schlieren, Switzerland, 21 July 2026 – arcoris bio, a Swiss life science research tools and in vitro diagnostics company, today announced a distribution partnership with Europa Biosite, a leading distributor of life science research products and services. Through this partnership, Europa Biosite will distribute arcoris bio’s newly launched immunoMUSE® kits in several European markets and across North America. With immunoMUSE®, researchers can create their own multiplex immunofluorescence panels using their preferred antibodies, combining flexibility with high sensitivity and ease of use.
arcoris bio’s MUSE® technology enables simultaneous detection of multiple biomarkers with exceptional sensitivity and simplified workflows. By supporting the detection of low-abundance targets within a single sample and enabling higher throughput, MUSE® is well positioned to advance applications in digital pathology and translational research.
“Europa Biosite is an ideal partner for arcoris bio as we continue to expand the reach of our MUSE® platform across Europe and North America,” said Matyas Vegh, CEO of arcoris bio. “immunoMUSE® gives researchers the freedom to build multiplex immunofluorescence panels with the antibodies they already trust, while benefiting from the exceptional sensitivity of our proprietary signal amplification technology. By combining our innovation with Europa Biosite’s extensive commercial and scientific network, we can help more researchers unlock valuable biological insights and advance the next generation of spatial biology and digital pathology applications.”
“We are excited to add immunoMUSE® to our portfolio of innovative life science solutions,” said Sebastian Buchert, Group Product Director at Europa Biosite. “The technology addresses a growing demand for highly sensitive and flexible multiplex immunofluorescence workflows. We believe immunoMUSE® offers researchers a unique opportunity to leverage their existing antibody expertise while achieving superior analytical performance, and we look forward to making this solution available to our customers across Europe and North America.”
For further information, please contact:
Beatrix Benz
+41 79 256 77 73
[email protected]
About immunoMUSE®
Compared to conventional staining approaches, immunoMUSE® improves signal-to-noise ratios, enabling more reliable detection of low-abundance biomarkers and increasing overall assay sensitivity.
It is well-suited for a broad range of research applications, including:
- Oncology: profiling tumor microenvironments and identifying rare or low-abundance biomarkers
- Neurobiology: studying complex neuronal networks and subtle protein expression patterns
- Immunology: characterizing immune cell populations and their interactions
- Spatial biology: enabling multiplexed biomarker analysis while preserving spatial context within tissues
The portfolio includes:
- immunoMUSE® Activate & Amplify kits: providing all reagents required to prepare user antibodies for use with the MUSE® system and perform staining.
- immunoMUSE® Amplify kits: additional amplification reagents for ongoing experiments and higher throughput.
About arcoris bio
arcoris bio develops next-generation technologies for biomarker detection in research and diagnostics. Its flagship MUSE® platform provides universal, programmable signal amplification to enable highly sensitive and multiplex assays that drive the future of digital pathology. The company is headquartered in Schlieren, Switzerland.
For more information, please visit: www.arcorisbio.com
About Europa Biosite
Europa Biosite is a leading supplier of life science products and services in Europe and North America. With a highly skilled team of over 200 employees, Europa Biosite is raising the standard of life science distribution.
For more information on Europa Biosite, please visit: www.europabiosite.com